US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 58.430
- +1.630+2.87%
Trading Nov 19 13:39 ET
118.51BMarket Cap-16321P/E (TTM)
58.435High56.100Low5.60MVolume56.300Open56.800Pre Close322.58MTurnover0.28%Turnover Ratio15.14P/E (Static)2.03BShares61.08052wk High6.91P/B118.29BFloat Cap38.43652wk Low2.40Dividend TTM2.02BShs Float75.083Historical High4.11%Div YieldTTM4.11%Amplitude7.783Historical Low57.587Avg Price1Lot Size
Bristol-Myers Squibb Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.44%11.89B | 8.69%12.2B | 4.66%11.87B | -2.50%45.01B | 0.62%11.48B | -2.25%10.97B | -5.56%11.23B | -2.67%11.34B | -0.49%46.16B | -4.83%11.41B |
| Operating revenue | 7.47%11.59B | 8.52%12.04B | 4.48%11.69B | -2.26%44.39B | 0.60%11.32B | -1.85%10.78B | -5.03%11.1B | -2.64%11.19B | -0.78%45.41B | -4.93%11.25B |
| Cost of revenue | 18.00%2.96B | 13.60%3.27B | 14.26%2.93B | 5.48%10.69B | 5.86%2.75B | 6.50%2.51B | 5.74%2.88B | 3.84%2.57B | 1.98%10.14B | 10.06%2.59B |
| Gross profit | 5.61%8.94B | 6.99%8.93B | 1.85%8.93B | -4.74%34.31B | -0.92%8.73B | -4.57%8.46B | -8.91%8.35B | -4.42%8.77B | -1.16%36.02B | -8.47%8.81B |
| Operating expense | 4.03%6.76B | 12.31%7.24B | 17.04%7.42B | -2.97%26.12B | -4.07%6.83B | -3.92%6.5B | -1.16%6.45B | -2.60%6.34B | -3.55%26.92B | -2.33%7.12B |
| Selling and administrative expenses | -1.00%1.98B | -0.31%1.93B | 34.34%2.37B | -0.54%7.77B | -8.52%2.07B | 3.78%2B | 8.23%1.93B | -3.77%1.76B | 1.61%7.81B | -3.74%2.27B |
| -Selling and marketing expense | -1.00%1.98B | ---- | 34.34%2.37B | ---- | ---- | 3.78%2B | ---- | -3.77%1.76B | ---- | ---- |
| Research and development costs | 5.89%2.37B | 28.39%2.9B | 16.11%2.7B | -2.21%9.3B | -1.27%2.48B | -7.28%2.24B | -2.71%2.26B | 2.70%2.32B | -6.73%9.51B | -0.32%2.51B |
| Depreciation amortization depletion | 6.65%2.41B | 7.04%2.42B | 4.48%2.36B | -5.71%9.05B | -2.77%2.28B | -6.70%2.26B | -6.62%2.26B | -6.66%2.26B | -4.27%9.6B | -3.06%2.34B |
| -Depreciation and amortization | 6.65%2.41B | 7.04%2.42B | 4.48%2.36B | -5.71%9.05B | -2.77%2.28B | -6.70%2.26B | -6.62%2.26B | -6.66%2.26B | -4.27%9.6B | -3.06%2.34B |
| Operating profit | 10.87%2.17B | -11.05%1.69B | -37.75%1.51B | -9.98%8.2B | 12.34%1.9B | -6.67%1.96B | -28.05%1.9B | -8.88%2.43B | 6.64%9.1B | -27.61%1.69B |
| Net non-operating interest income expense | -80.36%-505M | -84.75%-521M | -47.57%-425M | 5.36%-1.17B | -7.48%-316M | 6.35%-280M | 9.90%-282M | 11.66%-288M | 7.65%-1.23B | 8.98%-294M |
| Non-operating interest expense | 80.36%505M | 84.75%521M | 47.57%425M | -5.36%1.17B | 7.48%316M | -6.35%280M | -9.90%282M | -11.66%288M | -7.65%1.23B | -8.98%294M |
| Other net income (expense) | -98.03%9M | -51.67%116M | -2,113.58%-12.61B | 987.42%1.41B | -81.05%87M | 11.98%458M | 164.69%240M | 195.43%626M | -117.77%-159M | 388.68%459M |
| Gain on sale of security | -0.93%106M | 424.32%194M | 637.74%285M | 145.87%289M | -19.84%198M | 181.58%107M | 113.17%37M | 91.64%-53M | -180.36%-630M | --247M |
| Special income (charges) | -87.65%-456M | -65.94%-536M | -11,557.76%-13.29B | 63.99%-260M | -64.22%190M | -18.54%-243M | 42.32%-323M | 123.77%116M | 30.44%-722M | 24.36%531M |
| -Less：Restructuring and merger&acquisition | 48.73%409M | 41.52%467M | 6,258.37%13.29B | 14.46%1.51B | 350.32%698M | 70.81%275M | -39.34%330M | -54.66%209M | -2.15%1.32B | -24.76%155M |
| -Less:Impairment of capital assets | 62.07%47M | ---- | ---- | ---- | ---- | --29M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | 1,085.71%69M | 100.62%2M | -187.84%-390M | -97.95%3M | -238.64%-61M | -143.75%-7M | -236.55%-325M | 22.31%444M | 342.42%146M |
| -Gain on sale of business | ---- | ---- | ---- | -17.35%862M | ---- | ---- | ---- | ---- | 54.52%1.04B | 24.92%832M |
| Other non- operating income (expenses) | -39.56%359M | -12.93%458M | -28.77%401M | 15.84%1.38B | 5.64%-301M | 3.13%594M | 11.91%526M | 20.82%563M | 3.83%1.19B | -104.49%-319M |
| Income before tax | -21.57%1.68B | -30.82%1.29B | -515.74%-11.52B | 9.43%8.44B | -9.95%1.67B | -3.26%2.14B | -5.06%1.86B | 64.20%2.77B | -4.75%7.71B | 0.05%1.86B |
| Income tax | 127.09%461M | -82.57%-398M | -22.07%392M | -70.76%400M | 46.99%-88M | -66.22%203M | -141.21%-218M | 24.50%503M | 26.20%1.37B | 67.70%-166M |
| Net income | -37.18%1.22B | -18.92%1.68B | -625.28%-11.91B | 26.71%8.04B | -12.99%1.76B | 20.27%1.93B | 45.35%2.08B | 76.70%2.27B | -9.54%6.35B | -14.63%2.03B |
| Net income continuous Operations | -37.18%1.22B | -18.92%1.68B | -625.28%-11.91B | 26.71%8.04B | -12.99%1.76B | 20.27%1.93B | 45.35%2.08B | 76.70%2.27B | -9.54%6.35B | -14.63%2.03B |
| Minority interest income | -33.33%4M | 0.00%4M | -40.00%3M | -16.67%15M | 0 | 200.00%6M | -50.00%4M | 0.00%5M | -10.00%18M | 3M |
| Net income attributable to the parent company | -37.19%1.21B | -18.96%1.68B | -626.57%-11.91B | 26.84%8.03B | -12.86%1.76B | 20.05%1.93B | 45.88%2.07B | 77.00%2.26B | -9.54%6.33B | -14.76%2.02B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -37.19%1.21B | -18.96%1.68B | -626.57%-11.91B | 26.84%8.03B | -12.86%1.76B | 20.05%1.93B | 45.88%2.07B | 77.00%2.26B | -9.54%6.33B | -14.76%2.02B |
| Basic earnings per share | -36.17%0.6 | -16.16%0.83 | -645.37%-5.89 | 30.64%3.88 | -9.38%0.87 | 25.33%0.94 | 47.76%0.99 | 80.00%1.08 | -5.71%2.97 | -12.86%0.96 |
| Diluted earnings per share | -35.48%0.6 | -16.16%0.83 | -650.47%-5.89 | 30.85%3.86 | -8.42%0.87 | 24.00%0.93 | 50.00%0.99 | 81.36%1.07 | -5.45%2.95 | -11.21%0.95 |
| Dividend per share | 5.26%0.6 | 5.26%0.6 | 5.26%0.6 | 5.48%2.31 | 5.26%0.6 | 5.56%0.57 | 5.56%0.57 | 5.56%0.57 | 8.96%2.19 | 5.56%0.57 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
